<DOC>
	<DOCNO>NCT01337388</DOCNO>
	<brief_summary>This observational study ass efficacy safety RoActemra/Actemra ( Tocilizumab ) smoke versus non-smoking patient rheumatoid arthritis . Data patient treat routine clinical practice intravenous RoActemra/Actemra collect 12 month .</brief_summary>
	<brief_title>An Observational Study RoActemra/Actemra ( Tocilizumab ) Smoking Versus Non-Smoking Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; 18 year age Rheumatoid arthritis , define fulfil least 4 7 American College Rheumatology ( ACR ) criteria Treatment RoActemra/Actemra Participation interventional clinical study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>